rosiglitazone has been researched along with Diabetic Neuropathies in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gluch-Lutwin, M; Librowski, T; Nawiesniak, B; Sałat, K | 1 |
Patel, SS; Udayabanu, M | 1 |
Brosius, FC; Feldman, EL; Kretzler, M; Pennathur, S; Sullivan, KA; Wiggin, TD | 1 |
Abraira, C; Davis, SN; Duckworth, W; Emanuele, N; Goldman, S; Hayward, R; Henderson, WG; Huang, GD; Marks, J; McCarren, M; Moritz, T; Reaven, PD; Reda, D; Vitek, ME; Warren, SR; Zieve, FJ | 1 |
Rennings, AJ; Smits, P; Stewart, MW; Tack, CJ | 1 |
2 trial(s) available for rosiglitazone and Diabetic Neuropathies
Article | Year |
---|---|
Glucose control and vascular complications in veterans with type 2 diabetes.
Topics: Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Kaplan-Meier Estimate; Male; Metformin; Middle Aged; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; United States; Veterans | 2009 |
Autonomic neuropathy predisposes to rosiglitazone-induced vascular leakage in insulin-treated patients with type 2 diabetes: a randomised, controlled trial on thiazolidinedione-induced vascular leakage.
Topics: Adult; Aged; Capillary Permeability; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Rosiglitazone; Thiazolidinediones; Vasodilation | 2010 |
3 other study(ies) available for rosiglitazone and Diabetic Neuropathies
Article | Year |
---|---|
Evaluation of analgesic, antioxidant, cytotoxic and metabolic effects of pregabalin for the use in neuropathic pain.
Topics: 3T3-L1 Cells; Analgesics; Animals; Antioxidants; Cell Death; Diabetes Mellitus, Experimental; Diabetic Neuropathies; gamma-Aminobutyric Acid; Glucose; Hep G2 Cells; Humans; Hyperalgesia; Lipid Metabolism; Male; Mice; Motor Skills; Neuralgia; Pain Threshold; Pregabalin; Rosiglitazone; Terfenadine; Thiazolidinediones | 2013 |
Effect of Urtica dioica on memory dysfunction and hypoalgesia in an experimental model of diabetic neuropathy.
Topics: Animals; Avoidance Learning; Blood Glucose; Body Weight; Diabetic Neuropathies; Drug Therapy, Combination; Insulin; Maze Learning; Memory Disorders; Mice; Pain Threshold; Phytotherapy; Plant Extracts; Plant Leaves; Polydipsia; Rosiglitazone; Streptozocin; Thiazolidinediones; Urtica dioica | 2013 |
Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Female; Gene Expression; Genomics; Growth Hormone; Hyperalgesia; Hypoglycemic Agents; Male; Mice; Mice, Inbred DBA; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Promoter Regions, Genetic; Rosiglitazone; Thiazolidinediones | 2008 |